ConductScience.org, home

Paper39211666

Dorzagliatin: A Breakthrough Glucokinase Activator Coming on Board to Treat Diabetes Mellitus.

Raju R and 3 others. Cureus, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Dorzagliatin: A Breakthrough Glucokinase Activator Coming on Board to Treat Diabetes Mellitus. Papers, record 39211666. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39211666

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dorzagliatin: A Breakthrough Glucokinase Activator Coming on Board to Treat Diabetes Mellitus.
PubMed
Journal
Cureus
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.64, provisional
iCite
Revised in PubMed
2024-09-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Raju RRamya
2Prabath IIndumathi
3Chandrasekaran IIndumathi
4Varadarajan SSathyanarayanan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135551294Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial.Nat Med2022https://conductscience.org/library/papers/35551294PubMed
28954920Analysis of the pancreatic beta cell in the mouse with targeted disruption of the pancreatic beta cell-specific glucokinase gene.Biochem Biophys Res Commun1996https://conductscience.org/library/papers/8954920PubMed
35501259Glucose-induced electrical activity in pancreatic islet cells.J Physiol1970https://conductscience.org/library/papers/5501259PubMed
435067153Glucokinase as an emerging anti-diabetes target and recent progress in the development of its agonists.J Enzyme Inhib Med Chem2022https://conductscience.org/library/papers/35067153PubMed
529648519Glutamate dehydrogenase: role in regulating metabolism and insulin release in pancreatic β-cells.J Appl Physiol (1985)2018https://conductscience.org/library/papers/29648519PubMed
629735394Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study.Lancet Diabetes Endocrinol2018https://conductscience.org/library/papers/29735394PubMed
721994424Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes.Diabetes Care2011https://conductscience.org/library/papers/21994424PubMed
838203742New-Generation Glucokinase Activators: Potential Game-Changers in Type 2 Diabetes Treatment.Int J Mol Sci2024https://conductscience.org/library/papers/38203742PubMed
912869762Allosteric activators of glucokinase: potential role in diabetes therapy.Science2003https://conductscience.org/library/papers/12869762PubMed
1024739934Dynamic localization of glucokinase and its regulatory protein in hypothalamic tanycytes.PLoS One2014https://conductscience.org/library/papers/24739934PubMed
1121525462Glucokinase activators for diabetes therapy: May 2010 status report.Diabetes Care2011https://conductscience.org/library/papers/21525462PubMed
129278411Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism.J Biol Chem1997https://conductscience.org/library/papers/9278411PubMed
1336342518Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes.Diabetes2023https://conductscience.org/library/papers/36342518PubMed
1425440507Adherence to diabetes medication: a systematic review.Diabet Med2015https://conductscience.org/library/papers/25440507PubMed
154870741Metabolism of glucose in the islets of Langerhans.J Biol Chem1968https://conductscience.org/library/papers/4870741PubMed
1624606905Hypoglycemia-activated GLUT2 neurons of the nucleus tractus solitarius stimulate vagal activity and glucagon secretion.Cell Metab2014https://conductscience.org/library/papers/24606905PubMed
1727422385Sex-Specific Control of Fat Mass and Counterregulation by Hypothalamic Glucokinase.Diabetes2016https://conductscience.org/library/papers/27422385PubMed
1814060797EFFECTS OF CARBOHYDRATES ON SECRETION OF INSULIN FROM ISOLATED RAT PANCREAS.Am J Physiol1963https://conductscience.org/library/papers/14060797PubMed
1925802718Present status of clinical deployment of glucokinase activators.J Diabetes Investig2015https://conductscience.org/library/papers/25802718PubMed
2037385967Diabetes remission in drug-naïve patients with type 2 diabetes after dorzagliatin treatment: A prospective cohort study.Diabetes Obes Metab2023https://conductscience.org/library/papers/37385967PubMed

See all 41 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42791034Resetting the glucose sensor: dorzagliatin and the evolution of glucokinase activation in diabetes therapy.BMJ Open Diabetes Res Care2026https://conductscience.org/library/papers/42791034PubMed
41685165Activating protein kinases to treat diseases: Current understanding and future challenges.Acta Pharm Sin B2026https://conductscience.org/library/papers/41685165PubMed
41659332Dorzagliatin shows potential in preventing cognitive impairment in diabetes: evidence from Mendelian randomization analysis and animal study.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/41659332PubMed
41599685TAT-PBX1 Reverses Hyperglycemia Through β-Cell Regeneration and Functional Restoration in an STZ-Induced Diabetic Model.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41599685PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GCK2645PubTator's text mininghttps://conductscience.org/library/genes/2645

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39211666

GET https://conductscience.org/api/papers/v1/39211666/references?page=2